ARTICLE | Clinical News
Testosterone cream: Preliminary Phase III data
May 19, 2008 7:00 AM UTC
Ardana does not expect an open-label Phase III trial of ARD-0403 to meet its endpoint of 75% of patients reaching testosterone levels in the normal range. The company said the study's titration phase ...